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Summary: The diagnostic valüe of the low-molecular mass proteins ribonuclease, ß2-microglobulin, and
lysozyme in serum for the detection of reduced glomerular filtration rates was evaluated. The values of these
proteins and of serum creatinine investigated in 52 patients suffering from chronic renal diseases were plotted
against "m-Tc^diethylenetriäniinopentaäcetäte clearance äs an indicator of glomerular filtration rate. Log-
transformed data showed a gpod fit pf linearity. Considering the 95% confidence limits of the regression
equations, ribonuclease increased above the normal ränge when the glomerular filtration rate was lower than
1.24 ml/s whereas the other analytes partly remained within their normal limits. Out of those 18 patients
with glomerular filtration rates lower than 1.24 ml/s, all patients showed elevated ribonuclease levels. ß2-
Microglobülin, creatinine, and lysozyme were increased in 17, 14, and 12 cases, respectively. Ribonuclease
and ß2-microglobulin showed similar results when other diagnostic criteria (specificity, efficiency and predic-
tive values) were taken into account. We recommend ribonuclease determination in serum for the detection
of reduced glomerular filtration rate in the normal ränge of creatinine. The test is diagnostically powerful,
cheap and easy to perform.
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Introduction
In recent years, interest has been shown in the diag-
nostic power of low-molecular mass proteins in serum
and urine for the measurement of renal function (l —
6). ß2-Microglobulin (1—3), armicroglobulin (2, 3),
retinol-bmdmg protein (4, 5), lysozyme (6), and ri-
bonuclease (7) have been considered to be useful in
this respect. These proteins are freely filtered throügh
the capillary wall, then reabsorbed and catabolized in
the proximal tubule cells (8). Thus, if the glomerular
Filtration rate (GFR) in the kidney is reduced, the
concentrations of these proteins in serum increase
and may be taken äs suitable indicators of GFR. To
evaluate their diagnostic usefulness, we have com-
pared the behaviour of ribonuclease, ß2-microglobu-
lin and lysozyme in relation to creatinine and the
isotope clearance of 99mTc-diethylenetriaminopenta-
acetate (DTPA), which provides a good estimation
of GFR.
Materials and Methods
Reagents and apparatus
Micrococcus lysodeikticus was obtained from Ferak, West Ber-
lin; polycytidylic acid from Boehringer Mannheim GmbH,
Mannheim (FRG); imidazole from Fluka, Buchs (Switzerland);
crystalline egg-white lysozyme from Worthington Biochem.
Corp., Freehold (USA); and Phadezym ß2-microtest from Phar-
macia Fine Chemicals AB, Uppsala (Sweden). Other fine chemi-
cals of analytical grade were from E. Merck, Darmstadt (FRG).
""Tc-DTPA was supplied by Isocommerz GmbH, Berlin
(GDR).
We used 1001 M and ACP 5040 Eppendorf photometers and
pipettes (Eppendorf Gerätebau, Netheler & Hinz, Hamburg,
FRG), spectrophotometer DU-8 (Beckman Inc., Fullerton, CA,
USA), and a refrigerated centrifuge (Model K23; VEB Zentrifu-
genbau, Leipzig, DDR).
Procedures
Lysozyme was measured by an improved turbidimetric method,
monitoring the decrease in absorbance at 365 nm during 90 s
(9). For that purpose, equal volumes of serum samples and of
a 150 mmol/1 NaCl solution were mixed and 20 of this
mixture were added to 500 of Substrate solution. Final
concentrations in the reaction mixture were 70 mmol/1 phos-
phate buffer (pH 6.2) and 250 mg/1 Micrococcus lysodeikticus.
Crystalline egg-white lysozyme was used äs a Standard.
To determine the catalytic activity of serum ribonuclease, we
used a micromethod with polycytidylic acid äs Substrate, and
measurement of the release of acid-soluble ultra-viölet absorb-
ing products (10). The final concentrations in the reaction
mixture were 0.3 mmol/1 polycytidylic acid, 200 mmol/1 imidaz^
ole/HCl buffer (pH 7.0), and 50 mmol/1 NaCl. Results are
expressed äs kU/1. One unit is deflned äs the amount of enzyme
which produces l of acid-soluble nucleotides per min at
37 °C.
ß2-Microglobulin was measured according to the instructions öf
the suppliers of this test kit.
Creatinine was determined by a kinetic procedure (11).
Precision studies were performed using either suitable dilutiöns
of serum stored at —25 °C (ribonuclease, lysozyme) or control
materials (ß2-microglobulin, creatinine). Over an investigation
period of 14 days we obtained 43.9 ± 2.9 kU/1 ( ± l SD)
ribonuclease, 4.72 ± 0.33 mg/1 lysozyme, 2.72 ± 0.31 mg/1 ß2-
microglobulin, and 99 ± 2.6 /i ereatinine.
Glomerular filtration rate (GFR) was calculated by single corn-
partmeötal model analysis of the disappearance curve of 99mTc-
DTPA. 20 MBq of 99mTc-DTPA was injected into a medial
antecubital vein and radioaetivity was measured in blood sam-
ples taken 60, 90, and 120 min after injection. GFR values
were corrected to the body surface area of 1.73 m2.
Control group, patients, and samples
In this study, the control grpup (n = 63; 32 women, 31 men;
mean age 35 years) consisted of healthy blood donors and
laboratory staff with normal serum creatinine concenträtions.
The patient group (52) consisted of 33 women and ,19 men
(mean age 40 years) with chronic renal diseases (27 with chronic
pyelonephritis, 25 with chronic glomerulpnephritis). In all
cases, the diagnosis of glomerulonephritis was based on the
histological examination of kidney biopsy material. Py-
elonephritis was diagnosed by anamnestic mformationj usual
clinical chemical aiialyses, and X-ray and sonographic examina-
tions.
Blood samples were collected in the morning after an overnight
fast. The serum was separated and stored at — 25 °C until
analysis, which was performed not later than three weeks after
collection.
Statistical evaluation
For the Statistical analysis of the results the U-test according
to Mann-Whithey was used. Linear regression analysis was
performed on the HP 9835-A (Hewlett Packard, Paolo Alto,
USA).
Results
Table l comprises the data of controls and the com-
bined data of patients. A plot of low-molecular mass
protein and creatinine concentrations against DTPA
clearance values resulted in a non-linear relätionship.
We tested possible linear transformations of values
and, like others before us, found that log-transfonned
values produced a good fit of linearity (fig. la—d).
The slöpes of the ribonuclease and ßa-microglobulin
plots are significäntly higher (p < 0.05) .than those
of creatinine and lysozyme. These data prove that
ribonuclease and ß^microglqbulin increase more
strikingly than creatinine or lysozyme with a simülta-
neous GFR decrease.
The regression equations permit a calculation of the
corresponding DTPA values. For example, by using
the 99th percentiles of the control group äs upper
normal limits, the GFR values listed in table 2 are
obtained. As indieated by the 95% confidence limits,
there is a wide scatter.
.*
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Tab. 1. 99mTc-DTPA clearance and serum concentrations of
ribonuclease, 2-microglobulin, lysozyme, and crea-
tinine in the controls and patientsa.
DTPA clearance (ml/s)
Ribonuclease (kU/1)
2-Microglobulin (mg/1)
Lysozyme (mg/1)
Creatinine (μιηο1/1)
Controls6
(n = 63)
n.d.c
21.8 ± 5.1
1.8 ± 0.45
8.0 ± 2.1
81 ± 8.3
Patients
(n - 52)
1.57 ± 0.73
49.7 + 58.4*
3.88 ± 5.58*
15.3 ± 11.7*
122 ± 91*
Values are given s arithmetic means ± SD.
Comparisons were made between the control group and the
patients with the U-test; number of persons in parentheses.
Symbols: *p < 0.001.
n.d. = not determined; however, the arithmetic mean of
DTPA clearance determined on other healthy persons
(n = 34) amounted to 2.03 ± 0.34 ml/s.
Tab. 2. Upper reference limits of ribonuclease,
 2-microglobu-
lin, lysozyme, and creatinine in serum in relation to the
calculated GFR values.
Ribonuclease .
2-Microglobulin
Lysozyme
Creatinine
Concen-
trationa
33.7 kU/1
2.80 mg/1
12.9 mg/1
106 umol/1
Calculated GFR
value (ml/s)
1.43 (1.24-1.73)b
1.19 (1.04-1.44)
1.25 (1.04-1.69)
1.33 (1.16-1.60)
a
 99th percentiles of the three low-molecular mass proteins in
the control group (tab. 1) were calculated according to a
Gaussiaa distribution. These percentiles and 106 μιηοΐ/ΐ of
serum creatinine were considered s upper limits. The corre-
sponding GFR values were calculated from these data, taking
into account the regression equations of figures l a—d.
b
 The 95% confldence limits are given in parentheses.
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Fig. 1. Relationship of creatinine and low-molecular mass proteins in serum to WmTc-diethylenetriaminopentaacetate clearance
in 52 patients suffering from renal diseases.
log creatinine = 2.10 — 0.63 log diethylenetriaminopentaacetate; r = 0.867
log lysozyme = 1.17 — 0^63 log diethylenetriaminopentaacetate; r = —0.759
log ^mJcroglobulin = 0.52 — 1.03 log diethylenetriaminopentaacetate; r = —0.847
log ribonuclease = 1.68 — 0.96 log diethylenetriaminopentaacetate; r = 0,874.
The upper reference limits of the analytes and the lower limit of diethylenetriaminopentaacetate clearance are indicated.
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Since these comparisons hardly admit an assessment
of the diagnostic evidence of the tests, we reclassified
our patients by means of the measured concentrations
in relation to normal values. We considered the values
given in table 2 äs the upper limits for the three low-
molecular mass-proteins and creatinine. Taking into
account GFR values below the Ist percentile (1.24
ml/s) äs abnormal, we found decreased values in 18
patients out of the 52 patients studied. The validity
criteria of low-molecular mass proteins and creatinine
in relation to DTPA-clearance are given in table 3.
Ribonuclease and ß2-microglobulin showed compar-
able results.
Tab. 3. Diagnostic criteria of ribonuclease, ß2^microglobulin,
lysozyme, and creatinine for detecting reduced glp-
merular filtration rate. A cut-off point of 1.24 ml/s of
DTPA clearance was selected äs an indicator of reduced
GFR. 34 patients had higher, and 18 had lower values.
For further calculation (16), the upper reference limits
given in table 2 were considered. >
Criterion
Sensitivity
Specificity
Efficiency
Predictive value,
positive
Predictive value,
negative
Ribonu^
clease
1.0
0.94
0.96
0.90
1.00
ßr
Micro-
globulin
0.94
0.97
0.96
0.94
0.97
Lyso-
zyme
0.67
0.88
0.81
0.75
0.83
Creati-
nine
0.78
0.94
0.88
0.88
0.89
Discussion
Serum creatinine concentrations and endogenous
creatinine clearance are the most widely accepted
routine parameters for the detection of a reduced
glomerular filtration rate. Both parameters, however,
have a limited diagnostic validity. Serum creatinine
shows no response until the GFR is reduced by
approximately 40%, and endogenous creatinine
clearance is considered unreliable for preanalytical,
analytical and biological reasons (12). On the other
hand, precise methods of isotope clearance required
for an accurate determination of GFR are expensive,
time-consuming and not well-süited to routine deter-
mination. Reliable screening tests for predicting GFR
are an absolute necessity. An essential task of nephro-
logical research therefore is to develop non-invasive
methods for this purpose.
Recently, different low-molecular mass proteins have
been used to measure renal function. ß2-Microglobu-
lin (1 — 3), (Xi-microglobulin (2, 3), retinol-binding
protein (4, 5), lysozyme (6) and ribonuclease (7) are
considered to serve this purpose, but insufficient com-
parative data on their diagnostic value are available
(2, 3). ß2-Microglobulin is the most frequently used
low-molecular mass protein for estimating GFR.
Reasons for this preference may be the well-investi-
gated behaviour of the protein in different diseases
and the availability of commercial test kits fof its
determination. Kusano et al. (2) and Weber et al. (3)
compared the diagnostic power of ß2-microglobulin
and tti-microglobulin and pointed out the advantages
of the latter. In our study we did not determine <ii-
microglobulin, büt our results show that ribonuclease
has special diagnostic välüe for the detection of a
reduced GFR within the normal creatinine ränge. To
us this protein seems to be the most sensitivfe para-
meter in this study. This can be concluded from the
slopes of the regression equations and the results of
reclassification of the patients. Both ribonuclease and
ß2-microglobulin were more sensitive than creatinine
in predicting reduced GFR, whereas lysozyme is even
rather worse than creatinine. These observed differ-
ences may be due to different types of protein pro-
cessing in the kidney (8). The renal handliiig of low-
molecular mass proteins include glomerular filtration,
interaction with the receptors at the peritubular side,
reabsorption and intracellülar catabolism. These pro*
cesses are specific for particular proteins depending,
among others, on their molecular size, strueture, and
net Charge (8).
We also found increased concentrations of ß2-micro-
globulin and ribonuclease in patients with 99mTc-
DTPA values above 1.24 ml/s, when this value is
taken äs the lower normal limit of GFR.
Two essential reasons for this discrepancy have to
be taken into account: either the cut-off point of
99mTc-DTPA was unfavourably chpsen in cömpari-
son with those of the two proteins, or low-molecular
mass proteins were increased by other diseases in
these patients. E. g., ribonuclease was found to be
increased in patients sufferirig from malignant neo-
plasms and pancreatic disease (13, 14). ß2-Microglo-
buliii showed elevated concentrations in patients with
chronic liver diseases (15). However, since we ex-
cluded these "unspecific" reasons for increased ribo-
nuclease in our patients, we believe that ribonuclease
may serve äs a suitable indicator of a reduced GFR.
However, the large scatter of the GFR confidence
limits which correspond to tihe upper limit of ribo-
nuclease (and the other parameters) prove that these
values are not suitatele for the prediction of an accept-
able maniier.
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We therefore recommend the determination of the
catalytic activity concentration of ribonuclease äs a
screening test for detecting reduced glomerular flltra-
tion rate in patients suffering from renal diseases but
showing normal creatinine values. If more precise
Information about GFR is needed for patients with
increased ribonuclease values, an isotope method,
such äs 99mTc-DTPA clearance, should be applied. We
prefer the determination of ribonuclease, because this
test (which gives diagnostic results similar to those
obtained for ß2-microglobulin) is cheaper and easier
to perform than the ß2-microglobulin assay. Reagents
for one test cost about 15 cents compared with about
2 dollars for one determination of ß2-microglobulin.
One person can perfonn 100 to 200 determinations
per day.
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